These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10491434)

  • 61. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.
    Damiens E; El Yazidi I; Mazurier J; Duthille I; Spik G; Boilly-Marer Y
    J Cell Biochem; 1999 Sep; 74(3):486-98. PubMed ID: 10412049
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The physiology of p16(INK4A)-mediated G1 proliferative arrest.
    Shapiro GI; Edwards CD; Rollins BJ
    Cell Biochem Biophys; 2000; 33(2):189-97. PubMed ID: 11325039
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.
    Swanton C; Mann DJ; Fleckenstein B; Neipel F; Peters G; Jones N
    Nature; 1997 Nov; 390(6656):184-7. PubMed ID: 9367157
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4.
    Kubo A; Nakagawa K; Varma RK; Conrad NK; Cheng JQ; Lee WC; Testa JR; Johnson BE; Kaye FJ; Kelley MJ
    Clin Cancer Res; 1999 Dec; 5(12):4279-86. PubMed ID: 10632371
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation.
    Suzuki A; Hayashida M; Ito T; Kawano H; Nakano T; Miura M; Akahane K; Shiraki K
    Oncogene; 2000 Jul; 19(29):3225-34. PubMed ID: 10918579
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dissection of CDK4-binding and transactivation activities of p34(SEI-1) and comparison between functions of p34(SEI-1) and p16(INK4A).
    Li J; Muscarella P; Joo SH; Knobloch TJ; Melvin WS; Weghorst CM; Tsai MD
    Biochemistry; 2005 Oct; 44(40):13246-56. PubMed ID: 16201750
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients.
    Kannengiesser C; Brookes S; del Arroyo AG; Pham D; Bombled J; Barrois M; Mauffret O; Avril MF; Chompret A; Lenoir GM; Sarasin A; ; Peters G; Bressac-de Paillerets B
    Hum Mutat; 2009 Apr; 30(4):564-74. PubMed ID: 19260062
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation.
    Scaini MC; Rossi E; de Siqueira Torres PL; Zullato D; Callegaro M; Casella C; Quaggio M; Agata S; Malacrida S; Chiarion-Sileni V; Vecchiato A; Alaibac M; Montagna M; Mann GJ; Menin C; D'Andrea E
    Mutat Res; 2009 Dec; 671(1-2):26-32. PubMed ID: 19712690
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4.
    Byeon IJ; Li J; Ericson K; Selby TL; Tevelev A; Kim HJ; O'Maille P; Tsai MD
    Mol Cell; 1998 Feb; 1(3):421-31. PubMed ID: 9660926
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Absence of R24C mutation of the CDK4 gene in leukemias and solid tumors.
    Mori N; Yang R; Kawamata N; Miller CW; Mizoguchi H; Koeffler HP
    Int J Hematol; 2003 Apr; 77(3):259-62. PubMed ID: 12731669
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of growth of human leukemia cell lines by retrovirally expressed wild-type p16INK4A.
    Gombart AF; Yang R; Campbell MJ; Berman JD; Koeffler HP
    Leukemia; 1997 Oct; 11(10):1673-80. PubMed ID: 9324288
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice.
    Holland EC; Hively WP; DePinho RA; Varmus HE
    Genes Dev; 1998 Dec; 12(23):3675-85. PubMed ID: 9851974
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The cyclin-dependent kinase inhibitor p16INK4a physically interacts with transcription factor Sp1 and cyclin-dependent kinase 4 to transactivate microRNA-141 and microRNA-146b-5p spontaneously and in response to ultraviolet light-induced DNA damage.
    Al-Khalaf HH; Mohideen P; Nallar SC; Kalvakolanu DV; Aboussekhra A
    J Biol Chem; 2013 Dec; 288(49):35511-25. PubMed ID: 24163379
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Familial melanoma-associated mutations in p16 uncouple its tumor-suppressor functions.
    Jenkins NC; Jung J; Liu T; Wilde M; Holmen SL; Grossman D
    J Invest Dermatol; 2013 Apr; 133(4):1043-51. PubMed ID: 23190892
    [TBL] [Abstract][Full Text] [Related]  

  • 77. GRIM-19 and p16(INK4a) synergistically regulate cell cycle progression and E2F1-responsive gene expression.
    Sun P; Nallar SC; Raha A; Kalakonda S; Velalar CN; Reddy SP; Kalvakolanu DV
    J Biol Chem; 2010 Sep; 285(36):27545-52. PubMed ID: 20522552
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mutational analysis of the P16-binding domain of cyclin-dependent kinase 4 in tumors in the head region of the pancreas.
    Ceha HM; Clement MJ; Polak MM; Offerhaus GJ; Slebos RJ
    Pancreas; 1998 Jul; 17(1):85-8. PubMed ID: 9667525
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma.
    Parry D; Peters G
    Mol Cell Biol; 1996 Jul; 16(7):3844-52. PubMed ID: 8668202
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1).
    Sugimoto M; Nakamura T; Ohtani N; Hampson L; Hampson IN; Shimamoto A; Furuichi Y; Okumura K; Niwa S; Taya Y; Hara E
    Genes Dev; 1999 Nov; 13(22):3027-33. PubMed ID: 10580009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.